Pathway Genomics has been selected by San Diego Venture Group as one of 30 “cool companies to be featured at its 10th Annual Venture Summit on June 6.  

“The selection is a reminder that companies like Pathway are at the forefront of a major shift in the way medicine is practiced throughout the world,” said Jim Plante, Pathway’s founder and CEO.

“The selection is a reminder that companies like Pathway are at the forefront of a major shift in the way medicine is practiced throughout the world,” said Jim Plante, Pathway’s founder and CEO. Selected from a field of over 150 applicants, Pathway Genomics and the other 29 companies will be a prominent part of the event, which draws more than 100 venture capitalists and 500 attendees.

What We Do
Looking at millions of characters of genetic data is not typically thought of as, “Cool.” But, it’s what we provide that’s cool. Partially funded by Founders Fund (Facebook, SpaceX), Pathway screens genes associated with the propensity for drug responses, life-altering conditions, as well as food and exercise responses. We decode that information and turn it into easy-to-read reports for physicians and their patients, and in some cases, we give actionable advice they can use to optimize their health and wellness. Learn more about Pathway…

Comments are closed.